Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADiTx Therapeutics, Inc. | 4,702 | reported | 08 Nov 2023 | tx 15+581,712−73,610 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Nov 2023 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 4,702 | 0.00 USD | deriv |
| 22 Jul 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 10 Nov 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 75,000 | 0.00 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 100 | 2.89 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 1,000 | 2.95 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 1,000 | 2.95 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 500 | 2.93 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 800 | 2.90 USD | |
| 24 Feb 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 225,000 | 0.00 USD | |
| 02 Nov 2020 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 24 Jul 2020 | EXERCISE | ADiTx Therapeutics, Inc. | 35,555 | 11.25 USD | |
| 24 Jul 2020 | EXERCISE | ADiTx Therapeutics, Inc. | 38,055 | 11.25 USD | |
| 24 Jul 2020 | EXERCISE | ADiTx Therapeutics, Inc. | 35,555 | 11.25 USD | deriv |
| 24 Jul 2020 | EXERCISE | ADiTx Therapeutics, Inc. | 38,055 | 11.25 USD | deriv |